Wednesday, August 13th, 2025 - Day 2Wednesday, 13 August 2025 - EST/EDT (Eastern Daylight, GMT-4)

• Explore how to transition from basic monitoring data and investigations to prescriptive and predictive analytics for proactive compliance
• Focus on real-world applications of AI and data analytics in compliance monitoring, with case studies from companies successfully implementing these strategies
• Discuss the advantages and potential pitfalls of using AI in monitoring, including successful implementation examples and instances of unnecessary complexity

• Discuss how to develop and implement comprehensive training strategies for all field-based colleagues (sales, medical affairs, and other commercial roles) to ensure accurate HCP interaction reporting and compliance with internal policies and external regulations
• Explore strategies to simplify complex reporting requirements and compliance messages, providing clear guidance and practical examples to enable all end-users engaging with HCPs to understand and effectively execute accurate reporting practices
• Establish ongoing training and reinforcement programs for field teams, leveraging technology and real-world scenarios, to maintain consistent adherence to reporting and compliance standards

• Learn to effectively capture and categorize diverse spending related to clinical trials, including investigator payments, research grants, and associated expenses
• Discover optimal strategies for data collection and validation to minimize errors and ensure precise reporting of clinical trial expenditures

• Explore practical techniques to maximize data accuracy and integrity, critical for achieving reliable spend reporting
• Learn proven strategies for identifying and resolving data inconsistencies, including robust data audits, optimized systems, and streamlined processes, to guarantee complete and accurate aggregate spend submissions
• Focus on the hands-on application of data quality controls and validation techniques to enhance the integrity of reported data

• Focus on strategies for effective compliance in Life Sciences organizations & learn methods to streamline regulatory reporting
• Uncover common issues and practical approaches & empower your organization with tools and knowledge for better compliance processes

• Delve into the complexities of navigating fostering HCP relationships with regulatory uncertainties, prioritizing compliance with limited resources, and fostering a compliance culture from the outset
• Explore factors that are crucial for startups' long-term success and require innovative strategies tailored to their unique circumstances

• Navigate varying international regulations to adapt reporting programs and develop a unified global data framework for consistent compliance
• Address global compliance risks, prepare for audits (including emerging requirements), and optimize global program structure, including HCP engagement and transparency systems
• Gain insights into the complexities of speaker programs and other cross-border interactions with HCPs

• A walkthrough of the aggregate spend reporting process, from legislative preparation to report submission to dissecting common challenges facing manufacturers
• Learn how to identify and mitigate hidden risks preceding and throughout the reporting process, such as fragmented data sources, inconsistent HCP/HCO identifiers and shifting state and federal regulations
• Uncover reliable strategies to streamline your reporting processes, enhance overall reporting accuracy and reduce compliance risks

• Unpack the unique challenges and critical considerations of global monitoring interactions between US-based and ex-US entities
• Master how to effectively align and implement compliance initiatives across diverse jurisdictions, ensuring consistent monitoring and adherence to varying regulatory requirements

Join this interactive breakout session to gain targeted insights and practical solutions to elevate your monitoring program. This session is tailored to address specific monitoring challenges by company size: Small/Mid-Sized Companies and Large Companies.

For Small/Mid-Sized Pharma:

• Explore effective monitoring strategies within resource constraints, including first-line monitoring and vendor utilization
• Discover methods to enhance messaging, communication and training to secure organizational and leadership buy-in
• Learn how to design and scale a right-sized monitoring program, benchmarking against peers' successful approaches

For Large Pharma:

• Benchmark on the tools and strategies large companies employ to monitor travel and entertainment (T&E) expenses
• Discuss strategies to optimize a risk-based monitoring approach to efficiently manage high volumes of data

• Gain a deep understanding of the aggregate spend data pipeline, from initial capture to final reporting, and identify critical bottlenecks in the flow
• Learn how to connect disparate systems and departments, fostering collaboration and ensuring seamless data flow across the entire reporting lifecycle
• Discover proven methods for pinpointing and resolving data flow issues, leveraging upstream insights to optimize your reporting processes and prevent costly errors

Join interactive roundtables designed to address the most pressing challenges faced by transparency and aggregate spend professionals. Rotate through focused discussions on key topics, collaboratively sharing best practices and developing actionable solutions. This dynamic session will provide targeted strategies to optimize your reporting processes through knowledge exchange.

Designed for senior-level compliance and transparency experts, this session offers a unique opportunity to engage with peers and benchmark common challenges through shared practical experiences. Participants will collaboratively identify key pain points and areas of interest, shaping a tailored discussion led by expert facilitators. This interactive knowledge exchange fosters open collaboration and provides valuable insights for seasoned professionals.

*This summit is an exclusive, senior-level benchmarking discussion. Attendees should have a minimum of 5 years’ experience in compliance and transparency, and be currently employed at a bio/pharmaceutical or medical device manufacturer. Informa Connect reserves the right to qualify participants for this Summit. To reserve your seat, please email aiko.laski@informa.com.